-
Document de presse | 2017.03.31
A new approach for improving BCG
Scientists at the Institut Pasteur and their partners in the international TBVAC2020 consortium have just developed a tuberculosis vaccine candidate derived from conventional BCG. This vaccine candidate has higher efficacy, due to a heterologous system of protein secretion that increases the quality and magnitude of the immune responses to virulent strains of Mycobacterium tuberculosis – the...
-
Document de presse | 2019.05.09
Nipah outbreaks in Bangladesh: age and breathing difficulties of infected patients increase the risk of disease spread
Nipah virus, a bat-borne paramyxovirus found throughout South and South East Asia, has been identified by WHO as an emerging infectious disease that may cause severe epidemics in the near future. Infections in humans result in severe respiratory and neurological disease with a high case fatality. With no available treatment or vaccine, the control of Nipah virus outbreaks must rely on a detailed...
-
Fiche maladie | 2020.09.23
Meningococcal meningitis
Meningitis is an infection of the spinal cord and the brain membranes – or meninges –, caused by several types of virus, bacteria and fungi. Meningococci (another name for Neisseria meningitidis bacteria) are the main cause of acute meningitis. Despite treatment, meningococcal infections have a high mortality rate (10%) and considerable epidemic potential.
-
Article | 2017.03.27
Advice for Professionals
This section is for notaries, legal professionals and asset management experts. This is where you will find helpful information to advise your clients and documentation that may prove useful if you are currently working with the Bequests department on an estate. Two dedicated websites are also available : one for the Conference on philanthropic trusts and one for the Think tank on philanthropic...
-
Document de presse | 2024.11.08
The new face of “MAKE IT ICONIC. Choose France”, Professor Yasmine Belkaid embodies French boldness in the Government's international campaign
Professor Yasmine Belkaid, immunologist and President of the Institut Pasteur, has joined the international attractiveness campaign “MAKE IT ICONIC. Choose France*”, which aims to promote France's boldness and spirit of innovation, by showcasing the country's research, expertise, know-how and economic strength.A joint project between the French Ministry for Europe and Foreign Affairs’ Press and...
-
Document de presse | 2025.01.31
IRD, DNDi, Institut Pasteur de Guinée and the Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea
Guinea celebrates today the elimination of sleeping sickness (also known as human African trypanosomiasis or HAT) as a public health problem.Despite health crises such as the 2013-2015 Ebola epidemic and the SARS-Cov2 pandemic, combined medical and vector control strategies have enabled Guinea to reach the threshold of eliminating sleeping sickness as a public health problem (less than one case...
-
Document de presse | 2011.02.20
Unsuspected immune arsenal in infants
While completely protected from any infectious germs in their mother’s womb, fetuses spontaneously develop, “in advance”, an immune defense system ready to react to the bacterial colonization of their digestive tract at birth. This surprising observation made by scientists at the Institut Pasteur and the French National Center for Scientific Research (CNRS) also shows that this...
-
Document de presse | 2010.12.14
The brain: light-controlled neo-neurons
Researchers at the Institut Pasteur in association with the CNRS have just shown, in an experimental model, that newly formed neurons in the adult brain can be stimulated by light. A novel technique associating optical and genetic tools allows neurobiologists to render neo-neurons photo-excitable. For the first time they have prompted, observed, and specifically recorded the activity of...
-
Document de presse | 2010.01.19
A DNA microarray to detect emerging viruses
Teams at the Institut Pasteur and the French National Center for Scientific Research (CNRS) have succeeded in developing a tool that uses DNA microarray technology which can detect the presence of a virus or a known bacterium, or one of their emerging variants, within 24 hours. When the influenza A (H1N1) virus emerged in April 2009, the research teams showed that this microarray could detect and...
-
Document de presse | 2009.12.20
Biofilms: discovery of a new mechanism of virus propagation
Researchers at the Institut Pasteur and CNRS have shown for the first time that certain viruses are capable of forming complex biofilm-like assemblies, similar to bacterial biofilms. These extracellular infectious structures may protect viruses from the immune system and enable them to spread efficiently from cell to cell. "Viral biofilms" would appear to be a major mechanism of...